ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NFX Nuformix Plc

0.205
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Nuformix Plc LSE:NFX London Ordinary Share GB00BYW79Y38 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.205 0.18 0.23 61,432 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -859k -0.0012 -1.67 1.49M

Nuformix PLC Result of AGM (7285W)

20/08/2020 11:33am

UK Regulatory


Nuformix (LSE:NFX)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Nuformix Charts.

TIDMNFX

RNS Number : 7285W

Nuformix PLC

20 August 2020

Nuformix plc

("Nuformix" or the "Group")

Result of Annual General Meeting held on 20 August 2020

Cambridge, UK - 20 August 2020: Nuformix plc (LSE:NFX) announces that all resolutions proposed at its Annual General Meeting held today were duly passed on a poll, the results of which are set out below:

 
                                          Votes For     % of      Votes       % of    Votes Withheld 
                                                        Votes     Against     Votes         (1) 
                                                        Cast                  Cast 
      To receive the annual 
       report and accounts for 
       the year ended 31 March 
  1    2020                              160,439,143    97.06    4,859,946     2.94        3,215,648 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      To approve the remuneration 
       report contained within 
       the Annual Report for 
       the year ended 31 March 
  2    2020                              160,409,517    97.05    4,871,780     2.95        3,233,440 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      To re-appoint Jo Holland 
  3    as a director                     160,421,351    97.06    4,859,946     2.94        3,233,440 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      To re-appoint Christopher 
  4    Blackwell as a director           139,069,040    82.53   29,447,905    17.47           17,792 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      To appoint Karl Keegan 
  5    as a director                     139,057,206    82.52   29,459,739    17.48           17,792 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      To re-appoint Haysmacintyre 
  6    as auditor of the Company         160,439,143    97.06    4,859,946     2.94        3,215,648 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      To authorise the directors 
       to determine the remuneration 
  7    of the auditor                    160,421,351    97.05    4,877,738     2.95        3,215,648 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      To authorise the directors 
  8    to allot shares                   139,069,040    84.13   26,230,049    15.87        3,215,648 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      Authority to disapply 
       pre-emption without restriction 
  9    as to use (Special Resolution)    139,069,040    84.13   26,230,049    15.87        3,215,648 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      Authority to disapply 
       pre-emption for acquisitions 
       or specified capital 
       investments (Special 
 10    Resolution)                       148,518,064    84.99   26,230,049    15.01        3,215,648 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      To authorise the Company 
       to purchase its own shares 
 11    (Special Resolution)              169,876,333    97.21    4,871,780     2.79        3,215,648 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
      To authorise the Company 
       to call a general meeting 
       on not less than 14 clear 
       days' notice (Special 
 12    Resolution)                       148,506,230    84.98   26,241,883    15.02        3,215,648 
     ---------------------------------  ------------  -------  -----------  -------  --------------- 
 

(1) A vote withheld is not a vote under English law and is therefore not included in the calculation of votes for and against a resolution.

In accordance with Listing Rule 9.6.2, a copy of all resolutions passed as special business will shortly be available for inspection at the National Storage Mechanism document viewing facility at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Enquiries:

 
 Nuformix plc 
  Roger Jones, Company Secretary 
  Fleur Wood, Investor Relations 
  Email: fleur.wood@nuformix.com      +44 (0)1223 627222 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGBBLFLBVLXBBF

(END) Dow Jones Newswires

August 20, 2020 06:33 ET (10:33 GMT)

1 Year Nuformix Chart

1 Year Nuformix Chart

1 Month Nuformix Chart

1 Month Nuformix Chart

Your Recent History

Delayed Upgrade Clock